Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

25.78 +0.22 (+0.86%)
Official Closing Price Updated: 6:30 PM EDT, Jul 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
37 38 Next >
Graphic design as a service Company Doozoo secures strategic investment partner, launches fresh branding and expands resource within USA to meet growing global demand.
Via Get News
Arvinas Announces ARV-471 Achieves a Clinical Benefit Rate of 38% in Evaluable Patients and Continues to Show a Favorable Tolerability Profile in its Phase 2 Expansion Trial (VERITAC)
From Arvinas Inc.
Via GlobeNewswire
What the Latest Science Says About COVID-19 Testing and Treatment
Via StatePoint Media
Topics Death
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants
EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END 
Via FinancialNewsMedia
Four Healthcare Stocks To Watch This Week
Healthcare has long been a wise investment, as the industry consistently grows yearly. Some analysts believe that trend will continue. 
Via MarketBeat
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry. 
Via MarketBeat
Topics Intellectual Property
Glisser Agrees Strategic Partnership with American Express Global Business Travel
Via Get News
Physicians for Informed Consent Challenges the Basis for COVID-19 Vaccine Mandates
According to Physicians for Informed Consent, new data raise serious concerns over the risks of hospitalization in people vaccinated with the COVID-19 vaccine. 
Via Newswire.com
Topics Death
The Dr. Erik Goluboff Scholarship for Future Medical Doctors Available in the United States
Via Get News
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?
Learn more about Organicell Regenerative Medicine, Inc.from this latest report. 
Via TheNewswire.com
NYSE:PFE Investor Alert: Investigation over Possible Securities Laws Violations by Pfizer Inc.
San Diego, CA -- (SBWIRE) -- 11/10/2022 -- Pfizer Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
Drug Repurposing Market to Eyewitness Huge Growth by 2027 : Allergan, Astellas Pharma, Biovista, NuMedii
Stay up-to-date with Drug Repurposing Market research offered by AMA. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine
From Pfizer Inc.
Via Business Wire
Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma
From Pfizer Inc.
Via Business Wire
PFIZER REPORTS STRONG THIRD-QUARTER 2022 RESULTS AND RAISES 2022 OUTLOOK
From Pfizer Inc.
Via Business Wire
Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate
From Pfizer Inc.
Via Business Wire
Why Investors Are Suddenly Excited About Vaxcyte
Vaxcyte, Inc. is a small cap biotech company that catapulted back to mid-cap land with a stunning 110% surge — and may not be done yet. 
Via MarketBeat
Author A. D. Stowers' New Book 'Michaela's Miracle' is a Stirring True Story of Loss, Heartache and Joy Centered Around a Young Woman Who Comes to Understand Love
Recent release 'Michaela's Miracle' from Covenant Books author A. D. Stowers is an impactful tale based on true events that follow Michaela, who has only ever known rejection and abandonment her entire... 
Via Newswire.com
Pfizer Stock Falls After a Tax Investigation Is Launched Against the Company in Italy
Pfizer Stock (NYSE:PFE) According to a story published on Thursday by Reuters, which cited two individuals with knowledge of the situation, the tax authorities in Italy are probing the earnings... 
Via PressReach
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Pfizer Inc. (PFE) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Pfizer Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Pfizer Inc. (PFE) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Eli Lilly Dividend: Does Eli Lilly Pay Dividends?
Yes, Eli Lilly and Company (NYSE: LLY) pays dividends but there is more to investing in this stock than a simple “yes” answer. The Eli Lilly dividend is safe enough but it may not be right for all... 
Via MarketBeat
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Pfizer Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Pfizer Inc. (PFE) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Evaluate ERAS-007 and Palbociclib Combination
From Erasca, Inc.
Via GlobeNewswire
Pfizer Presents Scientific Advancements in Infectious Disease Prevention and Treatments at IDWeek 2022
From Pfizer Inc.
Via Business Wire
MarketBeat: Week in Review 10/10-10/14
A volatile week is ending with the market moving lower. Here are some of the stories the MarketBeat analysts were covering this week. 
Via MarketBeat
Pharma Trend Honors the Best Pharmaceutical Companies and the Most Innovative Products 2022
Via Magic PR
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.